Company: KROS
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001664710-25-000070
Chunk: 276

Company: Keros Therapeutics, Inc.
Filing Date: 2025-08-06
Form: 10-Q
Item: Item 8
Chunk 276
---
 year, or a lesser number of shares as may be determined by the Board. On January 1, 2025, the Company increased the number of shares available for future grant under the 2020 Plan by 1,622,188 shares. The awards granted under the 2020 Plan typically vest over a two- to four-year period and have a 10-year contractual term. As of June 30, 2025, there was an aggregate of 4,833,217 shares of common stock issuable upon the exercise of outstanding options and 867,775 shares of common stock issuable upon the vesting of the outstanding RSU awards under the 2020 Plan. Additionally, there were an aggregate of 1,689,821 shares reserved for future issuance under the 2020 Plan, including shares forfeited from the 2017 Plan.Restricted Stock UnitsA summary of RSU award activity during the six months ended June 30, 2025 is as follows (in thousands except share and per share data):Number of UnitsWeighted Average Grant-Date Fair ValueOutstanding RSU awards as of December 31, 2024— $— Granted940,175 10.75 Vested— — Forfeited(72,400)10.56 Outstanding RSU awards as of June 30, 2025867,775 $10.77 As of June 30, 2025, there was approximately $8.3 million of unrecognized stock-based compensation expense related to RSU awards that is expected to vest. These costs are expected to be recognized over a weighted-average remaining vesting period of approximately 1.64 years. Stock OptionsA summary of option activity during the six months ended June 30, 2025 is as follows (in thousands except share and per share data):NUMBER OF OPTIONSWEIGHTED-AVERAGE EXERCISE PRICEOutstanding as of December 31, 20245,384,760 $42.19 Granted84,000 14.82 Exercised(60,709)0.34 Cancelled or Forfeited (143,117)53.31 Expired(14,674)$47.90 Outstanding as of June 30, 20255,250,260 $41.92 Options exercisable as of June 30, 20253,465,140 $36.70 The summary of option activity includes performance-based stock options